Purpose: This AUA Guideline focuses on active surveillance (AS) and follow-up after
intervention for adult patients with clinically-localized renal masses suspicious for cancer …

The diagnosis of brain metastasis (BrM) has historically been a dooming diagnosis that is
nothing less than a death sentence, with few treatment options for palliation or prolonging …

Importance Patients with brain metastases from renal cell carcinoma (RCC) have been
underrepresented in clinical trials, and effective systemic therapy is lacking. Cabozantinib …

Brain metastases are a challenging manifestation of renal cell carcinoma. We have a limited
understanding of brain metastasis tumor and immune biology, drivers of resistance to …

BACKGROUND Patients with renal cell carcinoma (RCC) brain metastases are frequently
treated with immune checkpoint inhibitors (ICIs) and stereotactic radiosurgery (SRS) …

The incidence of small renal masses (SRM) is increasing around the world largely due to the
increasing use of abdominal imaging. 1, 2 Although 10–30% of these SRM are benign, the …

Background Nivolumab plus ipilimumab (NIVO+ IPI) has demonstrated long‐term efficacy
and safety in patients with previously untreated, advanced renal cell carcinoma (aRCC) …

Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …

Background Metastatic tumors are the most common malignancies of the central nervous
system (CNS) in adults. CNS metastases are associated with unfavorable prognosis, high …

OBJECTIVE Stereotactic radiosurgery (SRS) is the mainstay for treating brain metastases
(BMs) from renal cell carcinoma (RCC). In recent years, immune checkpoint inhibitors (ICIs) …